J Clin Oncol

期刊全称J Clin Oncol
注：上述信息均来源于网络，仅供查考，如有遗漏或信息错误，欢迎 向我反馈。

期刊相关文献 (10)

Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

西米普利单抗治疗肾移植后晚期皮肤鳞状细胞癌

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.23.01498
Glenn J Hanna ，Harita Dharanesswaran ，Anita Giobbie-Hurder ，John J Harran ，Zixi Liao ，Lori Pai ，Vatche Tchekmedyian ，Emily S Ruiz ，Abigail H Waldman ，Chrysalyne D Schmults ，Leonardo V Riella ，Patrick Lizotte ，Cloud P Paweletz ，Anil K Chandraker ，Naoka Murakami ，Ann W Silk
发表日期：2024
全文求助 收藏

Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial

纳武利尤单抗和瑞拉利单抗治疗接受过抗程序性死亡受体-1/程序性死亡配体1治疗后病情进展的晚期黑色素瘤患者：I/IIa期RELATIVITY-020试验结果

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.22.02072.
Paolo Antonio Ascierto,Evan J Lipson,Reinhard Dummer,James Larkin,Georgina V Long,Rachel E Sanborn,Vanna Chiarion-Sileni,Brigitte Dréno,Stéphane Dalle,Dirk Schadendorf,Margaret K Callahan,Marta Nyakas,Victoria Atkinson,Carlos Alberto Gomez-Roca,Naoya Yamazaki,Hussein A Tawbi,Naomey Sarkis,Deepti Warad,Sonia Dolfi,Priyam Mitra,Satyendra Suryawanshi,Jean-Jacques Grob
黑色素瘤
肿瘤
LAT
发表日期：2023
全文求助 收藏

Contribution of MEK Inhibition to BRAF/MEK Inhibitor Combination Treatment of BRAF-Mutant Melanoma: Part 2 of the Randomized, Open-Label, Phase III COLUMBUS Trial

MEK抑制剂对BRAF突变型黑色素瘤BRAF/MEK抑制剂联合治疗的贡献：随机、开放标签、III期COLUMBUS试验的第二部分

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.22.02322.
Paolo A Ascierto,Reinhard Dummer,Helen J Gogas,Ana Arance,Mario Mandala,Gabriella Liszkay,Claus Garbe,Dirk Schadendorf,Ivana Krajsova,Ralf Gutzmer,Vanna Chiarion-Sileni,Caroline Dutriaux,Jan Willem B de Groot,Naoya Yamazaki,Carmen Loquai,Caroline Robert,Keith T Flaherty
黑色素瘤
肿瘤
BRAF
COL
发表日期：2023
全文求助 收藏

Rare Germline ATM Variants Influence the Development of Chronic Lymphocytic Leukemia

罕见的生殖系ATM变异影响慢性淋巴细胞白血病的发展

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.22.00269
Benjamin L Lampson ，Aditi Gupta ，Svitlana Tyekucheva ，Kiyomi Mashima ，Anna Petráčková ，Zixu Wang ，Natalia Wojciechowska ，Conner J Shaughnessy ，Peter O Baker ，Stacey M Fernandes ，Samantha Shupe ，John-Hanson Machado ，Rayan Fardoun ，Annette S Kim ，Jennifer R Brown
发表日期：2023
全文求助 收藏

Randomized Phase III BMT CTN Trial of Calcineurin Inhibitor-Free Chronic Graft-Versus-Host Disease Interventions in Myeloablative Hematopoietic Cell Transplantation for Hematologic Malignancies

随机III期BMT CTN试验：在清髓性造血干细胞移植治疗血液系统恶性肿瘤中，不使用钙调神经磷酸酶抑制剂的慢性移植物抗宿主病干预措施的效果

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.21.02293.
Leo Luznik,Marcelo C Pasquini,Brent Logan,Robert J Soiffer,Juan Wu,Steven M Devine,Nancy Geller,Sergio Giralt,Helen E Heslop,Mary M Horowitz,Richard J Jones,Mark R Litzow,Adam Mendizabal,Lori Muffly,Eneida R Nemecek,Lynn O'Donnell,Richard J O'Reilly,Raquel Palencia,Johannes Schetelig,Leyla Shune,Scott R Solomon,Sumithira Vasu,Vincent T Ho,Miguel-Angel Perales
细胞生物学
肿瘤
神经科学
发育与干细胞
干细胞
发表日期：2022
全文求助 收藏

Small Cell Undifferentiated Histology Does Not Adversely Affect Outcome in Hepatoblastoma: A Report From the Children's Oncology Group (COG) AHEP0731 Study Committee

小细胞未分化组织学类型不影响肝母细胞瘤的预后：儿童肿瘤协作组 (COG) AHEP0731 研究委员会的报告

期刊:J Clin Oncol
影响因子:42.100
doi:PMC8824398
Angela Trobaugh-Lotrario，Howard M Katzenstein，Sarangarajan Ranganathan，Dolores Lopez-Terrada，Mark D Krailo，Jin Piao，Nadia Chung，Jessica Randazzo，Marcio H Malogolowkin，Wayne L Furman，Elizabeth B McCarville，Alexander J Towbin，Greg M Tiao，Stephen P Dunn，Max R Langham，Eugene D McGahren，James Feusner，Carlos Rodriguez-Galindo，Rebecka L Meyers，Allison F O'Neill，Milton J Finegold
细胞生物学
肿瘤
发表日期：2022
全文求助 收藏

Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors

儿童和青少年脑肿瘤患者下丘脑和垂体放射剂量与内分泌功能障碍的关系

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.2018.78.1492.
Ralph E Vatner,Andrzej Niemierko,Madhusmita Misra,Elizabeth A Weyman,Claire P Goebel,David H Ebb,Robin M Jones,Mary S Huang,Anita Mahajan,David R Grosshans,Arnold C Paulino,Takara Stanley,Shannon M MacDonald,Nancy J Tarbell,Torunn I Yock
免疫/内分泌
肿瘤
发表日期：2018
全文求助 收藏

Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016

在接受 CHOP 联合利妥昔单抗或 CHOP 联合 131I-托西莫单抗治疗的既往未接受过治疗的滤泡性淋巴瘤患者中，疗效持续良好：III 期随机研究 SWOG-S0016 的长期随访

期刊:J Clin Oncol
影响因子:42.100
doi:PMC6553811
Mazyar Shadman，Hongli Li，Lisa Rimsza，John P Leonard，Mark S Kaminski，Rita M Braziel，Catherine M Spier，Ajay K Gopal，David G Maloney，Bruce D Cheson，Shaker Dakhil，Michael LeBlanc，Sonali M Smith，Richard I Fisher，Jonathan W Friedberg，Oliver W Press
淋巴瘤
HOP
CHOP
发表日期：2018
全文求助 收藏

Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3

利用靶向癌症种系抗原 MAGE-A3 的主要组织相容性复合体 II 类限制性 T 细胞受体治疗转移性癌症患者

期刊:J Clin Oncol
影响因子:42.100
doi:PMC5652397
Yong-Chen Lu，Linda L Parker，Tangying Lu，Zhili Zheng，Mary Ann Toomey，Donald E White，Xin Yao，Yong F Li，Paul F Robbins，Steven A Feldman，Pierre van der Bruggen，Christopher A Klebanoff，Stephanie L Goff，Richard M Sherry，Udai S Kammula，James C Yang，Steven A Rosenberg
细胞生物学
肿瘤
MAG
发表日期：2017
全文求助 收藏

KIR3DL1 Allelic Polymorphism and HLA-B Epitopes Modulate Response to Anti-GD2 Monoclonal Antibody in Patients With Neuroblastoma

KIR3DL1等位基因多态性和HLA-B表位调节神经母细胞瘤患者对GD2单克隆抗体的反应

期刊:J Clin Oncol
影响因子:42.100
doi:10.1200/JCO.2015.64.9558
Christopher J Forlenza ，Jeanette E Boudreau ，Junting Zheng ，Jean-Benoît Le Luduec ，Elizabeth Chamberlain ，Glenn Heller ，Nai-Kong V Cheung ，Katharine C Hsu
发表日期：2016
全文求助 收藏
  • 1